scholarly journals Atypical cutaneous relapse of multiple myeloma

2021 ◽  
Vol 5 (1) ◽  
pp. 006-006
Author(s):  
Rieu Jean-Baptiste ◽  
Vergez Francois ◽  
Corre Jill ◽  
Perrot Aurore ◽  
Mouchel Pierre-Luc

A 66-year-old patient, diagnosed κ light chains MM with t(11;14), presented before second cycle with bendamustine-dexamethasone.

Author(s):  
Jan Fagerberg ◽  
Qing Yi ◽  
Dulceaydee Gigliotti ◽  
Ulrika Harmenberg ◽  
Ulla Rud�n ◽  
...  

Author(s):  
Eyal Lebel ◽  
Xuan Li ◽  
Harminder Paul ◽  
Esther Masih‐Khan ◽  
Sita Bhella ◽  
...  

1979 ◽  
Vol 25 (1) ◽  
pp. 190-192 ◽  
Author(s):  
F R Dalal ◽  
S Winsten

Abstract A patient with massive proteinuria was discovered to have double light-chain disease. Immunological studies demonstrated monoclonal light chains of both the lambda and kappa type in urine. The light chains were separate and distinct and were not found to be a part of any of the whole molecule immunoglobulins such as IgG, IgM, IgA, IgD, or IgE. Uniqueness of the proteins was confirmed by column chromatography. Clinical studies showed that the patient had multiple myeloma.


Blood ◽  
1978 ◽  
Vol 52 (3) ◽  
pp. 532-536 ◽  
Author(s):  
RH Kough ◽  
AZ Makary

Abstract Two cases of multiple myeloma (MM) developed late in the course of chronic lymphocytic leukemia (CLL). An 81-yr-old white female developed, after 6 yr of CLL, IgAk MM with sheets of plasma cells abutting sheets of lymphocytes in the bone marrow, multiple pathologic fractures, and 0.26 g/24 free k light chains in the urine. A 74-yr-old white male developed, after 16 yr of CLL, k light chain MM with 20% plasma cells in the bone marrow, multiple panthologic fractures, and 3.7 g/24 hr free k light chains in the urine. In both cases the CLL had responded well to intermittent low-dose chlorambucil therapy, but the MM failed to respond to cyclic melphalanprednisone therapy. A review of 105 cases of CLL seen at the Geisinger Medical Center failed to turn up any other cases of MM developing during the course of CLL. The suggestion that there is an increased prevalence of MM in CLL is an attractive one because both diseases are B cell neoplasms and because of the increased frequency of asymptomatic monoclonal gammopathies in CLL found by others.


1986 ◽  
Vol 32 (12) ◽  
pp. 2220-2221 ◽  
Author(s):  
M S Graziani ◽  
U Lippi

Abstract We report a rare finding: IgM kappa and Bence Jones lambda double gammopathy in serum of a 80-year-old man with untreated symptomatic multiple myeloma. The unusual findings are confined to the laboratory studies demonstrating also a Bence Jones lambda proteinuria, high erythrocyte sedimentation rate (113 mm/h), and anemia. The synthesis of the different light chains seems to occur in separate cellular clones.


2019 ◽  
Vol 12 (7) ◽  
pp. e229312
Author(s):  
Namrah Siddiq ◽  
Colin Bergstrom ◽  
Larry D Anderson ◽  
Srikanth Nagalla

Patients with multiple myeloma (MM) are at risk for acquired dysfibrinogenemia resulting in laboratory abnormalities and/or bleeding complications. We describe a 63-year-old man who presented with bleeding diathesis in the presence of a low fibrinogen activity level with a normal fibrinogen antigen level. Further studies revealed elevated levels of lambda free light chains, and he was diagnosed with MM. Despite initiating treatment with bortezomib/dexamethasone, he continued to have recurrent bleeds along with hypofibrinogenaemia, prompting a switch to carfilzomib/dexamethasone. The patient responded with improvement in bleeding symptoms, normalisation of fibrinogen activity and a decrease in serum free light chains.


2020 ◽  
Vol 8 (4) ◽  
pp. 617-624
Author(s):  
Uros Markovic ◽  
Valerio Leotta ◽  
Daniele Tibullo ◽  
Rachele Giubbolini ◽  
Alessandra Romano ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document